Name: ASND Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: ASND, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does ASND have?

Accepted Answer

Ascendis Pharma A/S (ASND) has 6 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 19, 2026.

Question 2

When was the most recent SEC Form 4 filing for ASND?

Accepted Answer

The most recent Form 4 filing for ASND on Tracefour is dated Aug 19, 2026.

Question 3

Who is the most active insider at ASND?

Accepted Answer

The most active SEC Form 4 filer at ASND in the rolling window is Director BIENAIME JEAN JACQUES, with 3 filings.

Question 4

What is the net insider flow at ASND over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at ASND have net sold $3.9M based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at ASND in the current window?

Accepted Answer

Inside the rolling window, insiders at ASND bought $777K and sold $4.6M based on SEC Form 4 filings.

Question 6

Can I get alerts for ASND insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Ascendis Pharma A/S (ASND). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
BIENAIME JEAN JACQUES	Director	Purchase	2,000	$493K	Aug 19	SEC ↗
SMITH SCOTT THOMAS	EVP & Chief Financial Officer	Purchase	100	$22K	Jun 2	SEC ↗
BIENAIME JEAN JACQUES	Director	Purchase	500	$112K	Jun 1	SEC ↗
SMITH SCOTT THOMASFirst filing	EVP & Chief Financial Officer	Purchase	250	$56K	Jun 1	SEC ↗
BIENAIME JEAN JACQUES	Director	Purchase	400	$95K	May 27	SEC ↗
JENSEN FLEMMING STEENFirst filing	See Remarks	Sale	19,460	$4.6M	May 12	SEC ↗

ASND

Related companies